Protocolised Management In Sepsis (ProMISe):A multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock

Health Technology Assessment

Volumn 19, Issue 97, 2015, Pages 1-150

  Mouncey, Paul R ^a   Osborn, Tiffany M ^b   Power, G Sarah ^a   Harrison, David A ^a   Sadique, M Zia ^c   Grieve, Richard D ^c   Jahan, Rahi ^a   Tan, Jermaine C K ^a   Harvey, Sheila E ^a   Bell, Derek ^d,e   Bion, Julian F ^f   Coats, Timothy J ^g   Singer, Mervyn ^h   Duncan Young, J ⁱ   Rowan, Kathryn M ^a  

^a King's College London   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g UNIVERSITY OF LEICESTER   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFUSION FLUID; VASOACTIVE AGENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEALTH CARE DELIVERY; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; KNOWLEDGE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PARALLEL DESIGN; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHOCK; TREATMENT PLANNING; UNITED KINGDOM; UNITED STATES; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMICS; ENGLAND; HOSPITAL EMERGENCY SERVICE; PROCEDURES; PROTOCOL COMPLIANCE; SHOCK, SEPTIC; TREATMENT OUTCOME;

ADULT; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; EMERGENCY SERVICE, HOSPITAL; ENGLAND; GUIDELINE ADHERENCE; HUMANS; RESUSCITATION; SHOCK, SEPTIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 84948746453     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19970     Document Type: Article

References (72)

1. Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012;2:010404.http://dx.doi.org/10.7189/jogh.01.010404
2. Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015;43:3–12. http://dx.doi.org/10.1097/CCM.0000000000000723
3. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 2014;311:1308–16. http://dx.doi.org/10.1001/jama.2014.2637
4. Cuthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, et al. ortality and quality of life in the five years after severe sepsis. Crit Care 2013;17:R70.http://dx.doi.org/10.1186/cc12616
5. Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Rockville, MD: Agency for Health Care Policy and Research (US); 2013.
6. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368–77.http://dx.doi.org/10.1056/NEJMoa010307
7. Kortgen A, Niederprum P, Bauer M. Implementation of an evidence-based ‘standard operating procedure’ and outcome in septic shock. Crit Care Med 2006;34:943–9. http://dx.doi.org/10.1097/01.CCM.0000206112.32673.D4
8. Sebat F, Johnson D, Musthafa AA, Watnik M, Moore S, Henry K, et al. A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients. Chest 2005;127:1729–43. http://dx.doi.org/10.1378/chest.127.5.1729
9. Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006;34:1025–32.http://dx.doi.org/10.1097/01.CCM.0000206104.18647.A8
10. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, et al. Before–after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006;34:2707–13. http://dx.doi.org/10.1097/01.CCM.0000241151.25426.D7
11. Shorr AF, Micek ST, Jackson WL Jr, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med 2007;35:1257–62.http://dx.doi.org/10.1097/01.CCM.0000261886.65063.CC
12. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007;35:1105–12.http://dx.doi.org/10.1097/01.CCM. 0000259463.33848.3D
13. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858–73.http://dx.doi.org/10.1097/01.CCM.0000117317.18092.E4
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41
15. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580–637. http://dx.doi.org/10.1097/CCM.0b013e31827e83af
16. Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004;32:S595–7. http://dx.doi.org/10.1097/01.CCM.0000147016.53607.C4
17. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012;12:919–24. http://dx.doi.org/10.1016/S1473-3099(12)70239-6
18. Ho BC, Bellomo R, McGain F, Jones D, Naka T, Wan L, et al. The incidence and outcome of septic shock patients in the absence of early-goal directed therapy. Crit Care 2006;10:R80.http://dx.doi.org/10.1186/cc4918
19. Chapman M, Gattas D, Suntharalingam G. Why is early goal-directed therapy successful – is it the technology? Crit Care 2005;9:307–8. http://dx.doi.org/10.1186/cc3726
20. Jones AE, Shapiro NI, Roshon M. Implementing early goal-directed therapy in the emergency setting: the challenges and experiences of translating research innovations into clinical reality in academic and community settings. Acad Emerg Med 2007;14:1072–8.http://dx.doi.org/10.1111/j.1553-2712.2007.tb02391.x
21. Turi SK, Von Ah D. Implementation of early goal-directed therapy for septic patients in the emergency department: a review of the literature. J Emerg Nurs 2013;39:13–19.http://dx.doi.org/10.1016/j.jen.2011.06.006
22. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005;294:218–28.http://dx.doi.org/10.1001/jama.294.2.218
23. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683–93.http://dx.doi.org/10.1056/NEJMoa1401602
24. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371:1496–506.http://dx.doiorg/10.1056/NEJMoa1404380
25. Huang DT, Angus DC, Barnato A, Gunn SR, Kellum JA, Stapleton DK, et al. Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock:methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med 2013;39:1760–75.http://dx.doi.org/10.1007/s00134-013-3024-7
26. Reade MC, Delaney A, Bailey MJ, Harrison DA, Yealy DM, Jones PG, et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 2010;36:11–21.http://dx.doi.org/10.1007/s00134-009-1650-x
27. Great Britain. Mental Capacity Act 2005. London: The Stationery Office; 2005.
28. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.http://dx.doi.org/10.1378/chest.101.6.1644
29. NHS and Department of Health. Saving Lives: Reducing Infection, Delivering Clean and Safe Care. High Impact Intervention No 1. Central Venous Catheter Care Bundle. URL: http://webarchive. nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_078134 (accessed 6 August 2014).
30. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10. http://dx.doi.org/10.1007/BF01709751
31. Information Standards Board for Health and Social Care. Critical Care Minimum Data Set Full Specification. London: Information Standards Board for Health and Social Care; 2010.
32. Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database. Crit Care 2004;8:R99–111.http://dx.doi.org/10.1186/cc2834
33. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–29. http://dx.doi.org/10.1097/00003246-198510000-00009
34. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31:670–5. http://dx.doi.org/10.1097/01.CCM.0000054867.01688.D1
35. Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev 2009;3:MR000008.
36. http://dx.doi.org/10.1002/14651858.mr000008.pub4
37. Harvey SE, Elbourne D, Ashcroft J, Jones CM, Rowan K. Informed consent in clinical trials in critical care: experience from the PAC-Man Study. Intensive Care Med 2006;32:2020–5. http://dx.doi.org/10.1007/s00134-006-0358-4
38. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377–99. http://dx.doi.org/10.1002/sim.4067
39. Power GS, Harrison DA, Mouncey PR, Osborn TM, Harvey SE, Rowan KM. The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan. Crit Care Resusc 2013;15:311–17.
40. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000;320:1197–200.http://dx.doi.org/10.1136/bmj.320.7243.1197
41. Survive Sepsis. The Sepsis Six. URL: https://survivesepsis.org/the-sepsis-six/(accessed24 December 2014).
42. Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT. Statistical assessment of the learning curves of health technologies. Health Technol Assess 2001;5(12).http://dx.doi.org/10.3310/hta5120
43. Gould WW, Pitblado J, Poi BP. Maximum Likelihood Estimation with Stata. 4th edn. College Station, TX: Stata Press; 2010.
44. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000;29:722–9.http://dx.doi.org/10.1093/ije/29.4.722
45. Goetghebeur E, Lapp K. The effect of treatment compliance in a placebo-controlled trial: regression with unpaired data. J R Stat Soc Ser C Appl Stat 1997;46:351–64. http://dx.doi.org/10.1111/1467-9876.00074
46. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London: NICE; 2013.
47. Hassan T, McMillan P, Walsh C, Higginson I. The Drive for Quality: How to Achieve Safe, Sustainable Care in our Emergency Departments? London: College of Emergency Medicine; 2013.
48. NHS Blood and Transplant. National Blood and Blood Products Price List 2011–2012. London: NHSBlood and Transplant; 2012.
49. Joint Formulary Committee. British National Formulary. 63rd edn. London: BMJ Group and Pharmaceutical Press; 2012.
50. Curtis L. Unit Costs of Health and Social Care 2012–13. Canterbury: Personal Social Services Research Unit, University of Kent; 2012.
51. Dixon S, Mason S, Knowles E, Colwell B, Wardrope J, Snooks H, et al. Is it cost effective to introduce paramedic practitioners for older people to the ambulance service? Results of a cluster randomised controlled trial. Emerg Med J 2009;26:446–51.http://dx.doi.org/10.1136/emj.2008.061424
52. Department of Health. National Schedule of Reference Costs, 2012–2013. London: Department of Health; 2013.
53. van Hout B, Devlin N. An EQ-5D-5L Value Set for England: Final Model Results. London: Office of Health Economics; 2014.
54. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96.http://dx.doi.org/10.1002/hec.944
55. Huang DT, Clermont G, Dremsizov TT, Angus DC. Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis. Crit Care Med 2007;35:2090–100. http://dx.doi.org/10.1097/01.CCM.0000281636.82971.92
56. Latimer NR. Survival analysis for economic evaluations alongside clinical trials – extrapolation with patient-level data: inconsistencies, limitations, and a practical guide. Med Decis Making 2013;33:743–54. http://dx.doi.org/10.1177/0272989X12472398
57. Soares MO, Welton NJ, Harrison DA, Peura P, Shankar Hari M, Harvey SE, et al. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 2012;16(7). http://dx.doi.org/10.3310/hta16070
58. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care 2010;14:R6. http://dx.doi.org/10.1186/cc8848
59. Ara R, Brazier JE. Populating an economic model with health state utility values: moving toward better practice. Value Health 2010;13:509–18. http://dx.doi.org/10.1111/j.1524-4733.2010.00700.x
60. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36.http://dx.doi.org/10.1007/s11136-011-9903-x
61. Talmor D, Greenberg D, Howell MD, Lisbon A, Novack V, Shapiro N. The costs andcost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med 2008;36:1168–74.http://dx.doi.org/10.1097/CCM.0b013e318168f649
62. Trzeciak S, Dellinger RP, Abate NL, Cowan RM, Stauss M, Kilgannon JH, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006;129:225–32.http://dx.doi.org/10.1378/chest.129.2.225
63. Manns BJ, Lee H, Doig CJ, Johnson D, Donaldson C. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002;347:993–1000. http://dx.doi.org/10.1056/NEJMsa020969
64. Fowler RA, Hill-Popper M, Stasinos J, Petrou C, Sanders GD, Garber AM. Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care 2003;18:181–91; discussion 91–4.http://dx.doi.org/10.1016/j.jcrc.2003.08.009
65. Cuthbertson BH, Scott J, Strachan M, Kilonzo M, Vale L. Quality of life before and after intensive care. Anaesthesia 2005;60:332–9. http://dx.doi.org/10.1111/j.1365-2044.2004.04109.x
66. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013;41:1167–74. http://dx.doi.org/10.1097/CCM.0b013e31827c09f8
67. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31.http://dx.doi.org/10.1007/s00134-009-1738-3
68. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 2014;42:625–31.http://dx.doi.org/10.1097/CCM.0000000000000026
69. Durston W. Does adoption of a regional sepsis protocol reduce mortality? Am J Emerg Med 2014;32:280–1. http://dx.doi.org/10.1016/j.ajem.2013.11.035
70. Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care – reasons for caution. N Engl J Med 2014;370:1673–6.http://dx.doi.org/10.1056/NEJMp1400276
71. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–54. http://dx.doi.org/10.1056/NEJMoa022139
72. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409–17. http://dx.doi.org/10.1056/NEJM199902113400601